Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
10.59
-3.58 (-25.26%)
At close: Jun 25, 2025, 4:00 PM
10.68
+0.09 (0.85%)
After-hours: Jun 25, 2025, 6:52 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $69.72 million as of June 25, 2025. Its market cap has increased by 222.77% in one year.
Market Cap
69.72M
Enterprise Value
23.86M
1-Year Change
222.77%
Ranking
Category
Stock Price
$10.59
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $69.72M, a decrease of -67.35%. That is a compound annual growth rate of -12.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 93.30M | 181.02% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.83B |
| Johnson & Johnson | 364.09B |
| AbbVie | 324.59B |
| Novo Nordisk | 309.67B |
| UnitedHealth Group | 272.76B |
| Abbott Laboratories | 231.85B |
| Novartis AG | 229.25B |
| AstraZeneca | 218.15B |